Glenview Trust CO Eli Lilly & CO Transaction History

Glenview Trust CO

$4.84 Billion
Q2 2024

A detailed history of Glenview Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Glenview Trust CO holds 193,106 shares of LLY stock, worth $169 Million. This represents 3.61% of its overall portfolio holdings.

Number of Shares

193,106

Previous 197,579 2.26%

Holding current value

$169 Million

Previous $154 Million 13.74%

% of portfolio

3.61%

Previous 3.35%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $3.24 Million - $4.07 Million	-4,473 Reduced 2.26%	193,106 $175 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $651,420 - $871,508	1,100 Added 0.56%	197,579 $154 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $549,348 - $647,609	-1,046 Reduced 0.53%	196,479 $115 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $5.95 Million - $8.2 Million	-13,679 Reduced 6.48%	197,525 $106 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $7.65 Million - $10.2 Million	-21,819 Reduced 9.36%	211,204 $99.1 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $29.5 Million - $34.6 Million	94,826 Added 68.62%	233,023 $80 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $759,179 - $884,595	-2,361 Reduced 1.68%	138,197 $50.6 Million
Q3 2022 Nov 04, 2022	SELL	$296.48 - $337.87 $647,215 - $737,570	-2,183 Reduced 1.53%	140,558 $45.5 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $2.33 Million - $2.73 Million	-8,348 Reduced 5.53%	142,741 $46.3 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $1.01 Million - $1.26 Million	4,314 Added 2.94%	151,089 $43.3 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $813,057 - $1.01 Million	3,616 Added 2.53%	146,775 $40.5 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $688,732 - $847,582	3,108 Added 2.22%	143,159 $33.1 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $3.61 Million - $4.67 Million	19,991 Added 16.65%	140,051 $32.1 Million
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $7.83 Million - $10.1 Million	47,638 Added 65.78%	120,060 $22.4 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $48,531 - $64,218	-372 Reduced 0.51%	72,422 $12.2 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $239,508 - $277,034	-1,638 Reduced 2.2%	72,794 $10.8 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $424,948 - $511,420	-3,115 Reduced 4.02%	74,432 $12.2 Million
Q1 2020 Apr 28, 2020	BUY	$119.05 - $147.35 $8,571 - $10,609	72 Added 0.09%	77,547 $10.8 Million
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $160,166 - $198,380	-1,498 Reduced 1.9%	77,475 $10.2 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $222,123 - $241,612	2,080 Added 2.71%	78,973 $8.83 Million
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $271,435 - $316,834	-2,450 Reduced 3.09%	76,893 $0
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $28,161 - $33,148	-253 Reduced 0.32%	79,343 $10.3 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $39,500 - $44,252	373 Added 0.47%	79,596 $9.21 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $9,873 - $12,340	-115 Reduced 0.14%	79,223 $8.5 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $135,275 - $155,254	-1,787 Reduced 2.2%	79,338 $6.77 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $79,404 - $93,732	-1,070 Reduced 1.3%	81,125 $0
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $53,670 - $57,567	-655 Reduced 0.79%	82,195 $6.94 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $6.39 Million - $7.09 Million	82,850	82,850 $7.09 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.

Account

Glenview Trust CO Eli Lilly & CO Transaction History